RA Capital Management, L.P. 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA |
RA Capital Management, L.P. | 21,539,465 9.990% |
2,869,376 (+15.37%) |
Filing |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
RA Capital Management, L.P. | 18,670,089 9.990% |
-20,779 (-0.11%) |
Filing |
| 2023-08-25 5:01 pm Purchase |
2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA |
RA Capital Management, L.P. | 18,690,868 9.990% |
18,690,868 (New Position) |
Filing |